Phase 3 Checkpoint 459 Trial: Nivolumab in advanced HCC - 101341

Spotlight
Video

Phase 3 Checkpoint 459 Trial: Nivolumab in advanced HCC

obr has 439 videos Subscribe Here

Loading........
Description: Nevena Damnjanov, MD of Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania gives an overview of what she learned from the phase III trial, Checkpoint 459, on the use of nivolumab in advanced HCC. This was recorded at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Shared By : obr
Posted on : 06/20/17
Added : 1 year ago
Category : Liver Cancer